NASDAQ
Arrowhead Pharmaceuticals, Inc. (ARWR) has a interest coverage ratio of 1.10x as of Wednesday, July 15, 2026. This represents a 114.79% increase compared to its 12-month average of -7.44x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.